| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.
|
Arthritis Rheum
|
2006
|
5.03
|
|
2
|
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.
|
Hepatology
|
2010
|
3.03
|
|
3
|
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.
|
Semin Arthritis Rheum
|
2010
|
2.88
|
|
4
|
Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
|
N Engl J Med
|
2003
|
2.81
|
|
5
|
Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
|
Arthritis Rheum
|
2012
|
2.75
|
|
6
|
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
|
J Natl Cancer Inst
|
2006
|
2.23
|
|
7
|
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.
|
Arthritis Rheum
|
2003
|
2.17
|
|
8
|
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
|
Arthritis Rheum
|
2010
|
2.08
|
|
9
|
Causes of death in patients with celiac disease in a population-based Swedish cohort.
|
Arch Intern Med
|
2003
|
1.88
|
|
10
|
Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.
|
Gastroenterology
|
2009
|
1.85
|
|
11
|
Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease.
|
Circulation
|
2011
|
1.85
|
|
12
|
Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
|
Gastroenterology
|
2010
|
1.83
|
|
13
|
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.81
|
|
14
|
Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001.
|
J Rheumatol
|
2006
|
1.72
|
|
15
|
Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
|
Arthritis Rheum
|
2013
|
1.70
|
|
16
|
No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
|
Arthritis Rheum
|
2009
|
1.68
|
|
17
|
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology.
|
Ann Rheum Dis
|
2010
|
1.63
|
|
18
|
Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis.
|
Int J Cancer
|
2002
|
1.62
|
|
19
|
Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
|
Arthritis Rheum
|
2011
|
1.60
|
|
20
|
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.
|
Arthritis Rheum
|
2011
|
1.57
|
|
21
|
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
|
PLoS Genet
|
2013
|
1.54
|
|
22
|
Rheumatoid arthritis and malignant lymphomas.
|
Curr Opin Rheumatol
|
2004
|
1.46
|
|
23
|
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
|
BMJ
|
2013
|
1.43
|
|
24
|
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.
|
Ann Rheum Dis
|
2010
|
1.41
|
|
25
|
Cystic fibrosis gene mutations and gastrointestinal diseases.
|
J Cyst Fibros
|
2010
|
1.39
|
|
26
|
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.
|
Gastroenterology
|
2003
|
1.34
|
|
27
|
Perinatal characteristics and risk of rheumatoid arthritis.
|
BMJ
|
2003
|
1.26
|
|
28
|
Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease.
|
J Natl Cancer Inst
|
2011
|
1.23
|
|
29
|
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
|
Clin Gastroenterol Hepatol
|
2008
|
1.19
|
|
30
|
Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease.
|
Arthritis Rheum
|
2008
|
1.19
|
|
31
|
Smoking, use of moist snuff, and risk of chronic inflammatory diseases.
|
Am J Respir Crit Care Med
|
2010
|
1.06
|
|
32
|
Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease.
|
Scand J Gastroenterol
|
2008
|
1.05
|
|
33
|
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
|
Arthritis Rheum
|
2012
|
1.00
|
|
34
|
Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study.
|
BMJ
|
2012
|
1.00
|
|
35
|
Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.
|
Arthritis Rheum
|
2006
|
0.99
|
|
36
|
Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration.
|
Arthritis Care Res (Hoboken)
|
2013
|
0.98
|
|
37
|
Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.98
|
|
38
|
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.
|
Arthritis Res Ther
|
2010
|
0.97
|
|
39
|
Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
|
Arthritis Rheum
|
2010
|
0.97
|
|
40
|
Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.
|
Gastroenterology
|
2009
|
0.96
|
|
41
|
Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
|
JAMA
|
2012
|
0.96
|
|
42
|
Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis.
|
Ann Rheum Dis
|
2012
|
0.94
|
|
43
|
Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women.
|
Arthritis Res Ther
|
2013
|
0.93
|
|
44
|
Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.
|
Ann Rheum Dis
|
2009
|
0.93
|
|
45
|
How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
|
Ann Rheum Dis
|
2011
|
0.92
|
|
46
|
Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma.
|
Int J Cancer
|
2006
|
0.92
|
|
47
|
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease.
|
Inflamm Bowel Dis
|
2007
|
0.91
|
|
48
|
Body size at birth and adulthood and the risk for germ-cell testicular cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.91
|
|
49
|
Increased risk of autoimmune disease in families with Wegener's granulomatosis.
|
J Rheumatol
|
2010
|
0.90
|
|
50
|
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
|
Br J Haematol
|
2008
|
0.87
|
|
51
|
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
|
Ann Rheum Dis
|
2013
|
0.87
|
|
52
|
Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.
|
J Rheumatol
|
2012
|
0.87
|
|
53
|
Cancer risk among patients with cystic fibrosis and their first-degree relatives.
|
Int J Cancer
|
2009
|
0.86
|
|
54
|
Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype.
|
Dig Liver Dis
|
2011
|
0.85
|
|
55
|
Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden.
|
Pediatrics
|
2003
|
0.85
|
|
56
|
Ten years with biologics: to whom do data on effectiveness and safety apply?
|
Rheumatology (Oxford)
|
2010
|
0.85
|
|
57
|
The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy.
|
Ann Rheum Dis
|
2006
|
0.84
|
|
58
|
The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.
|
Arthritis Res Ther
|
2014
|
0.84
|
|
59
|
Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.
|
Arthritis Rheum
|
2009
|
0.83
|
|
60
|
Women smoking and testicular cancer: one epidemic causing another?
|
Int J Cancer
|
2004
|
0.83
|
|
61
|
Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden.
|
BMC Cancer
|
2014
|
0.82
|
|
62
|
To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?
|
Arthritis Rheumatol
|
2015
|
0.82
|
|
63
|
Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study.
|
Ann Rheum Dis
|
2012
|
0.82
|
|
64
|
Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives.
|
Arthritis Care Res (Hoboken)
|
2013
|
0.81
|
|
65
|
Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County.
|
BMC Musculoskelet Disord
|
2014
|
0.80
|
|
66
|
Influence of biological agents on cardiovascular disease in rheumatoid arthritis.
|
Ann Rheum Dis
|
2011
|
0.79
|
|
67
|
Occupational risk factors for Wegener's granulomatosis: a case-control study.
|
Ann Rheum Dis
|
2009
|
0.79
|
|
68
|
Colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer.
|
Inflamm Bowel Dis
|
2010
|
0.78
|
|
69
|
Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
|
Ann Rheum Dis
|
2012
|
0.78
|
|
70
|
Maternal breast cancer risk after the death of a child.
|
Int J Cancer
|
2004
|
0.78
|
|
71
|
Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.
|
Ann Rheum Dis
|
2014
|
0.75
|
|
72
|
Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries.
|
Ann Rheum Dis
|
2013
|
0.75
|
|
73
|
Reply: To PMID 22886739.
|
Arthritis Rheum
|
2013
|
0.75
|
|
74
|
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2011
|
0.75
|
|
75
|
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
|
Acta Oncol
|
2004
|
0.75
|
|
76
|
Parental longevity and survival in elderly patients with Hodgkin's lymphoma.
|
Haematologica
|
2002
|
0.75
|
|
77
|
[Observational cohort studies. Overview and some examples from the field of drug safety].
|
Lakartidningen
|
2013
|
0.75
|
|
78
|
Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers.
|
Rheumatology (Oxford)
|
2010
|
0.75
|
|
79
|
Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma.
|
Am J Epidemiol
|
2017
|
0.75
|
|
80
|
Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis.
|
J Natl Cancer Inst
|
2002
|
0.75
|